PCSK9 Inhibitor Improves Cardiac Function and Reduces Infarct Size in Rats With Ischaemia/Reperfusion Injury: Benefits Beyond Lipid‐lowering Effects
Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/jcmm.14586
Full Text
Open PDFAbstract
Available in full text
Date
September 26, 2019
Authors
Publisher
Wiley